nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.487	0.735	CbGaD
Isoprenaline—ADRB3—type 2 diabetes mellitus	0.176	0.265	CbGaD
Isoprenaline—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0211	1	CbGbCtD
Isoprenaline—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00943	0.2	CbGeAlD
Isoprenaline—ADRBK1—peripheral nervous system—type 2 diabetes mellitus	0.00517	0.11	CbGeAlD
Isoprenaline—PIK3R1—retina—type 2 diabetes mellitus	0.00241	0.0512	CbGeAlD
Isoprenaline—PIK3R3—cardiovascular system—type 2 diabetes mellitus	0.00239	0.0507	CbGeAlD
Isoprenaline—PIK3R1—nephron tubule—type 2 diabetes mellitus	0.00227	0.0482	CbGeAlD
Isoprenaline—PIK3R3—adipose tissue—type 2 diabetes mellitus	0.00211	0.0447	CbGeAlD
Isoprenaline—PIK3R1—cortex of kidney—type 2 diabetes mellitus	0.00194	0.0412	CbGeAlD
Isoprenaline—MAPK1—islet of Langerhans—type 2 diabetes mellitus	0.00192	0.0408	CbGeAlD
Isoprenaline—PIK3R1—adipose tissue—type 2 diabetes mellitus	0.0018	0.0382	CbGeAlD
Isoprenaline—MAPK1—nephron tubule—type 2 diabetes mellitus	0.00155	0.0329	CbGeAlD
Isoprenaline—ADRBK1—cardiovascular system—type 2 diabetes mellitus	0.00141	0.0299	CbGeAlD
Isoprenaline—MAPK1—cardiovascular system—type 2 diabetes mellitus	0.00139	0.0295	CbGeAlD
Isoprenaline—ADRBK1—kidney—type 2 diabetes mellitus	0.00138	0.0293	CbGeAlD
Isoprenaline—MAPK1—kidney—type 2 diabetes mellitus	0.00136	0.0289	CbGeAlD
Isoprenaline—MAPK1—pancreas—type 2 diabetes mellitus	0.00135	0.0287	CbGeAlD
Isoprenaline—Pulmonary oedema—Rosiglitazone—type 2 diabetes mellitus	0.00133	0.0155	CcSEcCtD
Isoprenaline—Pallor—Bromocriptine—type 2 diabetes mellitus	0.00133	0.0155	CcSEcCtD
Isoprenaline—MAPK1—cortex of kidney—type 2 diabetes mellitus	0.00132	0.0281	CbGeAlD
Isoprenaline—ADRB3—adipose tissue—type 2 diabetes mellitus	0.00127	0.027	CbGeAlD
Isoprenaline—PIK3R1—liver—type 2 diabetes mellitus	0.00126	0.0268	CbGeAlD
Isoprenaline—ADRBK1—adipose tissue—type 2 diabetes mellitus	0.00124	0.0264	CbGeAlD
Isoprenaline—MAPK1—adipose tissue—type 2 diabetes mellitus	0.00123	0.026	CbGeAlD
Isoprenaline—Pulmonary oedema—Pioglitazone—type 2 diabetes mellitus	0.00111	0.013	CcSEcCtD
Isoprenaline—Pallor—Gliclazide—type 2 diabetes mellitus	0.00109	0.0127	CcSEcCtD
Isoprenaline—Sweating—Nateglinide—type 2 diabetes mellitus	0.000978	0.0115	CcSEcCtD
Isoprenaline—Angina pectoris—Repaglinide—type 2 diabetes mellitus	0.000965	0.0113	CcSEcCtD
Isoprenaline—Ventricular arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000963	0.0113	CcSEcCtD
Isoprenaline—MAPK1—liver—type 2 diabetes mellitus	0.00086	0.0183	CbGeAlD
Isoprenaline—Vertigo—Tolazamide—type 2 diabetes mellitus	0.000774	0.00905	CcSEcCtD
Isoprenaline—Angina pectoris—Pioglitazone—type 2 diabetes mellitus	0.000765	0.00895	CcSEcCtD
Isoprenaline—Tremor—Nateglinide—type 2 diabetes mellitus	0.000747	0.00874	CcSEcCtD
Isoprenaline—Angina pectoris—Glimepiride—type 2 diabetes mellitus	0.000745	0.00872	CcSEcCtD
Isoprenaline—Arrhythmia—Repaglinide—type 2 diabetes mellitus	0.000708	0.00829	CcSEcCtD
Isoprenaline—Masoprocol—IGF1R—type 2 diabetes mellitus	0.000708	0.161	CrCbGaD
Isoprenaline—Palpitations—Nateglinide—type 2 diabetes mellitus	0.000705	0.00825	CcSEcCtD
Isoprenaline—Sweating—Glipizide—type 2 diabetes mellitus	0.000701	0.0082	CcSEcCtD
Isoprenaline—Sweating—Pioglitazone—type 2 diabetes mellitus	0.000671	0.00786	CcSEcCtD
Isoprenaline—Sweating—Glimepiride—type 2 diabetes mellitus	0.000654	0.00765	CcSEcCtD
Isoprenaline—Pulmonary oedema—Irbesartan—type 2 diabetes mellitus	0.000635	0.00743	CcSEcCtD
Isoprenaline—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000629	0.00736	CcSEcCtD
Isoprenaline—Palpitations—Repaglinide—type 2 diabetes mellitus	0.00061	0.00714	CcSEcCtD
Isoprenaline—Flushing—Glipizide—type 2 diabetes mellitus	0.000609	0.00713	CcSEcCtD
Isoprenaline—Pulmonary oedema—Losartan—type 2 diabetes mellitus	0.000597	0.00699	CcSEcCtD
Isoprenaline—Hypertension—Repaglinide—type 2 diabetes mellitus	0.000596	0.00697	CcSEcCtD
Isoprenaline—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.00059	0.0125	CbGeAlD
Isoprenaline—Arrhythmia—Glipizide—type 2 diabetes mellitus	0.000586	0.00686	CcSEcCtD
Isoprenaline—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.000563	0.00659	CcSEcCtD
Isoprenaline—Tension—Glipizide—type 2 diabetes mellitus	0.000561	0.00656	CcSEcCtD
Isoprenaline—Nervousness—Glipizide—type 2 diabetes mellitus	0.000555	0.00649	CcSEcCtD
Isoprenaline—Angina pectoris—Gliclazide—type 2 diabetes mellitus	0.000552	0.00646	CcSEcCtD
Isoprenaline—Arrhythmia—Glimepiride—type 2 diabetes mellitus	0.000547	0.0064	CcSEcCtD
Isoprenaline—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000538	0.0063	CcSEcCtD
Isoprenaline—Tremor—Glipizide—type 2 diabetes mellitus	0.000535	0.00626	CcSEcCtD
Isoprenaline—Tension—Glimepiride—type 2 diabetes mellitus	0.000523	0.00612	CcSEcCtD
Isoprenaline—Tension—Sitagliptin—type 2 diabetes mellitus	0.000521	0.0061	CcSEcCtD
Isoprenaline—ADRB1—adipose tissue—type 2 diabetes mellitus	0.00052	0.011	CbGeAlD
Isoprenaline—Fenoterol—ADRB3—type 2 diabetes mellitus	0.000518	0.118	CrCbGaD
Isoprenaline—Nervousness—Glimepiride—type 2 diabetes mellitus	0.000518	0.00606	CcSEcCtD
Isoprenaline—Nervousness—Sitagliptin—type 2 diabetes mellitus	0.000516	0.00604	CcSEcCtD
Isoprenaline—Vertigo—Glipizide—type 2 diabetes mellitus	0.000513	0.00601	CcSEcCtD
Isoprenaline—Nausea—Miglitol—type 2 diabetes mellitus	0.00051	0.00597	CcSEcCtD
Isoprenaline—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.000506	0.00592	CcSEcCtD
Isoprenaline—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000504	0.0059	CcSEcCtD
Isoprenaline—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000502	0.00588	CcSEcCtD
Isoprenaline—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.000501	0.00586	CcSEcCtD
Isoprenaline—Tremor—Glimepiride—type 2 diabetes mellitus	0.000499	0.00584	CcSEcCtD
Isoprenaline—Arrhythmia—Bromocriptine—type 2 diabetes mellitus	0.000493	0.00577	CcSEcCtD
Isoprenaline—Hypertension—Glipizide—type 2 diabetes mellitus	0.000493	0.00577	CcSEcCtD
Isoprenaline—Vertigo—Pioglitazone—type 2 diabetes mellitus	0.000492	0.00575	CcSEcCtD
Isoprenaline—Arbutamine—ADRB3—type 2 diabetes mellitus	0.000484	0.11	CrCbGaD
Isoprenaline—Sweating—Gliclazide—type 2 diabetes mellitus	0.000484	0.00567	CcSEcCtD
Isoprenaline—Headache—Tolbutamide—type 2 diabetes mellitus	0.000484	0.00566	CcSEcCtD
Isoprenaline—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.000477	0.00559	CcSEcCtD
Isoprenaline—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000472	0.00553	CcSEcCtD
Isoprenaline—Tension—Bromocriptine—type 2 diabetes mellitus	0.000472	0.00552	CcSEcCtD
Isoprenaline—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000471	0.00551	CcSEcCtD
Isoprenaline—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000467	0.00547	CcSEcCtD
Isoprenaline—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.000467	0.00547	CcSEcCtD
Isoprenaline—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000465	0.00544	CcSEcCtD
Isoprenaline—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000465	0.00544	CcSEcCtD
Isoprenaline—Convulsion—Glimepiride—type 2 diabetes mellitus	0.000462	0.0054	CcSEcCtD
Isoprenaline—Angina pectoris—Metformin—type 2 diabetes mellitus	0.000462	0.0054	CcSEcCtD
Isoprenaline—Hypertension—Glimepiride—type 2 diabetes mellitus	0.00046	0.00539	CcSEcCtD
Isoprenaline—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000459	0.00537	CcSEcCtD
Isoprenaline—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000459	0.00537	CcSEcCtD
Isoprenaline—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000453	0.0053	CcSEcCtD
Isoprenaline—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000451	0.00527	CcSEcCtD
Isoprenaline—Headache—Tolazamide—type 2 diabetes mellitus	0.00044	0.00515	CcSEcCtD
Isoprenaline—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00044	0.00515	CcSEcCtD
Isoprenaline—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.000436	0.0051	CcSEcCtD
Isoprenaline—Headache—Linagliptin—type 2 diabetes mellitus	0.000436	0.0051	CcSEcCtD
Isoprenaline—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.000432	0.00506	CcSEcCtD
Isoprenaline—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000432	0.00505	CcSEcCtD
Isoprenaline—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00043	0.00504	CcSEcCtD
Isoprenaline—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000425	0.00497	CcSEcCtD
Isoprenaline—Insomnia—Glipizide—type 2 diabetes mellitus	0.000422	0.00493	CcSEcCtD
Isoprenaline—Flushing—Gliclazide—type 2 diabetes mellitus	0.000421	0.00492	CcSEcCtD
Isoprenaline—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000421	0.00492	CcSEcCtD
Isoprenaline—Nausea—Tolazamide—type 2 diabetes mellitus	0.000417	0.00488	CcSEcCtD
Isoprenaline—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000417	0.00488	CcSEcCtD
Isoprenaline—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000417	0.00488	CcSEcCtD
Isoprenaline—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000416	0.00486	CcSEcCtD
Isoprenaline—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000415	0.00486	CcSEcCtD
Isoprenaline—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000414	0.00485	CcSEcCtD
Isoprenaline—Tremor—Glyburide—type 2 diabetes mellitus	0.000412	0.00482	CcSEcCtD
Isoprenaline—Angina pectoris—Losartan—type 2 diabetes mellitus	0.00041	0.0048	CcSEcCtD
Isoprenaline—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000406	0.00476	CcSEcCtD
Isoprenaline—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000405	0.00474	CcSEcCtD
Isoprenaline—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000404	0.00473	CcSEcCtD
Isoprenaline—Nausea—Acarbose—type 2 diabetes mellitus	0.000401	0.00469	CcSEcCtD
Isoprenaline—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000398	0.00466	CcSEcCtD
Isoprenaline—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000393	0.0046	CcSEcCtD
Isoprenaline—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000392	0.00459	CcSEcCtD
Isoprenaline—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000388	0.00454	CcSEcCtD
Isoprenaline—Tension—Gliclazide—type 2 diabetes mellitus	0.000387	0.00453	CcSEcCtD
Isoprenaline—Nausea—Nateglinide—type 2 diabetes mellitus	0.000387	0.00452	CcSEcCtD
Isoprenaline—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000383	0.00449	CcSEcCtD
Isoprenaline—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000383	0.00448	CcSEcCtD
Isoprenaline—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000382	0.00447	CcSEcCtD
Isoprenaline—Convulsion—Glyburide—type 2 diabetes mellitus	0.000381	0.00446	CcSEcCtD
Isoprenaline—CYP1A1—kidney—type 2 diabetes mellitus	0.000372	0.0079	CbGeAlD
Isoprenaline—Tremor—Gliclazide—type 2 diabetes mellitus	0.00037	0.00433	CcSEcCtD
Isoprenaline—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000367	0.00429	CcSEcCtD
Isoprenaline—Sweating—Losartan—type 2 diabetes mellitus	0.00036	0.00421	CcSEcCtD
Isoprenaline—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000355	0.00415	CcSEcCtD
Isoprenaline—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000355	0.00415	CcSEcCtD
Isoprenaline—Headache—Repaglinide—type 2 diabetes mellitus	0.000353	0.00413	CcSEcCtD
Isoprenaline—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000352	0.00412	CcSEcCtD
Isoprenaline—Flushing—Metformin—type 2 diabetes mellitus	0.000352	0.00412	CcSEcCtD
Isoprenaline—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000352	0.00411	CcSEcCtD
Isoprenaline—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.00035	0.00409	CcSEcCtD
Isoprenaline—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000349	0.00408	CcSEcCtD
Isoprenaline—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000347	0.00406	CcSEcCtD
Isoprenaline—Labetalol—ADRB3—type 2 diabetes mellitus	0.000344	0.078	CrCbGaD
Isoprenaline—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000342	0.004	CcSEcCtD
Isoprenaline—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000342	0.004	CcSEcCtD
Isoprenaline—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000341	0.00399	CcSEcCtD
Isoprenaline—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000338	0.00395	CcSEcCtD
Isoprenaline—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000336	0.00712	CbGeAlD
Isoprenaline—Hypotension—Glyburide—type 2 diabetes mellitus	0.000335	0.00392	CcSEcCtD
Isoprenaline—Nausea—Repaglinide—type 2 diabetes mellitus	0.000335	0.00392	CcSEcCtD
Isoprenaline—Asthenia—Glipizide—type 2 diabetes mellitus	0.000334	0.00391	CcSEcCtD
Isoprenaline—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000334	0.0039	CcSEcCtD
Isoprenaline—Flushing—Irbesartan—type 2 diabetes mellitus	0.000332	0.00389	CcSEcCtD
Isoprenaline—Pindolol—ADRB3—type 2 diabetes mellitus	0.00033	0.0749	CrCbGaD
Isoprenaline—Vertigo—Valsartan—type 2 diabetes mellitus	0.000326	0.00381	CcSEcCtD
Isoprenaline—Vertigo—Orlistat—type 2 diabetes mellitus	0.000322	0.00377	CcSEcCtD
Isoprenaline—Palpitations—Valsartan—type 2 diabetes mellitus	0.00032	0.00375	CcSEcCtD
Isoprenaline—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00032	0.00375	CcSEcCtD
Isoprenaline—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00032	0.00374	CcSEcCtD
Isoprenaline—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00032	0.00374	CcSEcCtD
Isoprenaline—Palpitations—Orlistat—type 2 diabetes mellitus	0.000317	0.00371	CcSEcCtD
Isoprenaline—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000316	0.0037	CcSEcCtD
Isoprenaline—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000314	0.00368	CcSEcCtD
Isoprenaline—Flushing—Losartan—type 2 diabetes mellitus	0.000313	0.00366	CcSEcCtD
Isoprenaline—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000312	0.00365	CcSEcCtD
Isoprenaline—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000311	0.00364	CcSEcCtD
Isoprenaline—Vision blurred—Metformin—type 2 diabetes mellitus	0.000311	0.00364	CcSEcCtD
Isoprenaline—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000311	0.00364	CcSEcCtD
Isoprenaline—Convulsion—Orlistat—type 2 diabetes mellitus	0.00031	0.00363	CcSEcCtD
Isoprenaline—Tremor—Metformin—type 2 diabetes mellitus	0.000309	0.00362	CcSEcCtD
Isoprenaline—Sweating—Ramipril—type 2 diabetes mellitus	0.000309	0.00361	CcSEcCtD
Isoprenaline—Dizziness—Glipizide—type 2 diabetes mellitus	0.000308	0.00361	CcSEcCtD
Isoprenaline—Tension—Irbesartan—type 2 diabetes mellitus	0.000306	0.00358	CcSEcCtD
Isoprenaline—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000303	0.00354	CcSEcCtD
Isoprenaline—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000301	0.00352	CcSEcCtD
Isoprenaline—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000301	0.00352	CcSEcCtD
Isoprenaline—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000295	0.00346	CcSEcCtD
Isoprenaline—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000294	0.00344	CcSEcCtD
Isoprenaline—Headache—Glipizide—type 2 diabetes mellitus	0.000292	0.00342	CcSEcCtD
Isoprenaline—Tremor—Irbesartan—type 2 diabetes mellitus	0.000292	0.00342	CcSEcCtD
Isoprenaline—Palpitations—Metformin—type 2 diabetes mellitus	0.000292	0.00342	CcSEcCtD
Isoprenaline—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000291	0.00341	CcSEcCtD
Isoprenaline—Tension—Losartan—type 2 diabetes mellitus	0.000288	0.00337	CcSEcCtD
Isoprenaline—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000288	0.00337	CcSEcCtD
Isoprenaline—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000287	0.00336	CcSEcCtD
Isoprenaline—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000287	0.00336	CcSEcCtD
Isoprenaline—Hypertension—Metformin—type 2 diabetes mellitus	0.000285	0.00334	CcSEcCtD
Isoprenaline—Nervousness—Losartan—type 2 diabetes mellitus	0.000285	0.00333	CcSEcCtD
Isoprenaline—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000283	0.00331	CcSEcCtD
Isoprenaline—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000282	0.00329	CcSEcCtD
Isoprenaline—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00028	0.00328	CcSEcCtD
Isoprenaline—Headache—Pioglitazone—type 2 diabetes mellitus	0.00028	0.00327	CcSEcCtD
Isoprenaline—Droxidopa—ADRB3—type 2 diabetes mellitus	0.000278	0.0632	CrCbGaD
Isoprenaline—Nausea—Glipizide—type 2 diabetes mellitus	0.000277	0.00324	CcSEcCtD
Isoprenaline—Hypotension—Valsartan—type 2 diabetes mellitus	0.000277	0.00324	CcSEcCtD
Isoprenaline—Vision blurred—Losartan—type 2 diabetes mellitus	0.000276	0.00323	CcSEcCtD
Isoprenaline—Tremor—Losartan—type 2 diabetes mellitus	0.000275	0.00322	CcSEcCtD
Isoprenaline—Headache—Glimepiride—type 2 diabetes mellitus	0.000273	0.00319	CcSEcCtD
Isoprenaline—Headache—Sitagliptin—type 2 diabetes mellitus	0.000272	0.00318	CcSEcCtD
Isoprenaline—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000269	0.00315	CcSEcCtD
Isoprenaline—Flushing—Ramipril—type 2 diabetes mellitus	0.000268	0.00314	CcSEcCtD
Isoprenaline—Insomnia—Valsartan—type 2 diabetes mellitus	0.000268	0.00313	CcSEcCtD
Isoprenaline—Insomnia—Orlistat—type 2 diabetes mellitus	0.000265	0.0031	CcSEcCtD
Isoprenaline—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000264	0.00309	CcSEcCtD
Isoprenaline—Vertigo—Losartan—type 2 diabetes mellitus	0.000264	0.00308	CcSEcCtD
Isoprenaline—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000261	0.00305	CcSEcCtD
Isoprenaline—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00026	0.00304	CcSEcCtD
Isoprenaline—Palpitations—Losartan—type 2 diabetes mellitus	0.000259	0.00303	CcSEcCtD
Isoprenaline—Nausea—Glimepiride—type 2 diabetes mellitus	0.000258	0.00302	CcSEcCtD
Isoprenaline—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000258	0.00302	CcSEcCtD
Isoprenaline—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000258	0.00301	CcSEcCtD
Isoprenaline—Asthenia—Glyburide—type 2 diabetes mellitus	0.000257	0.00301	CcSEcCtD
Isoprenaline—Hypotension—Metformin—type 2 diabetes mellitus	0.000252	0.00295	CcSEcCtD
Isoprenaline—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000248	0.0029	CcSEcCtD
Isoprenaline—Tension—Ramipril—type 2 diabetes mellitus	0.000247	0.00289	CcSEcCtD
Isoprenaline—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000246	0.00288	CcSEcCtD
Isoprenaline—Headache—Bromocriptine—type 2 diabetes mellitus	0.000246	0.00288	CcSEcCtD
Isoprenaline—Nervousness—Ramipril—type 2 diabetes mellitus	0.000244	0.00286	CcSEcCtD
Isoprenaline—Dyspnoea—Metformin—type 2 diabetes mellitus	0.00024	0.00281	CcSEcCtD
Isoprenaline—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000238	0.00278	CcSEcCtD
Isoprenaline—Tremor—Ramipril—type 2 diabetes mellitus	0.000236	0.00276	CcSEcCtD
Isoprenaline—CYP1A1—liver—type 2 diabetes mellitus	0.000235	0.005	CbGeAlD
Isoprenaline—Norepinephrine—ADRB3—type 2 diabetes mellitus	0.000234	0.0532	CrCbGaD
Isoprenaline—Tachycardia—Losartan—type 2 diabetes mellitus	0.000234	0.00273	CcSEcCtD
Isoprenaline—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000233	0.00273	CcSEcCtD
Isoprenaline—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000231	0.00271	CcSEcCtD
Isoprenaline—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000231	0.0027	CcSEcCtD
Isoprenaline—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000227	0.00265	CcSEcCtD
Isoprenaline—Vertigo—Ramipril—type 2 diabetes mellitus	0.000226	0.00264	CcSEcCtD
Isoprenaline—Headache—Glyburide—type 2 diabetes mellitus	0.000225	0.00263	CcSEcCtD
Isoprenaline—Hypotension—Losartan—type 2 diabetes mellitus	0.000224	0.00262	CcSEcCtD
Isoprenaline—Palpitations—Ramipril—type 2 diabetes mellitus	0.000222	0.0026	CcSEcCtD
Isoprenaline—Convulsion—Ramipril—type 2 diabetes mellitus	0.000218	0.00255	CcSEcCtD
Isoprenaline—Insomnia—Losartan—type 2 diabetes mellitus	0.000217	0.00253	CcSEcCtD
Isoprenaline—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000213	0.0025	CcSEcCtD
Isoprenaline—Nausea—Glyburide—type 2 diabetes mellitus	0.000213	0.00249	CcSEcCtD
Isoprenaline—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000213	0.00249	CcSEcCtD
Isoprenaline—Epinephrine—ADRB3—type 2 diabetes mellitus	0.000212	0.0483	CrCbGaD
Isoprenaline—Asthenia—Valsartan—type 2 diabetes mellitus	0.000212	0.00248	CcSEcCtD
Isoprenaline—Asthenia—Orlistat—type 2 diabetes mellitus	0.00021	0.00246	CcSEcCtD
Isoprenaline—Headache—Gliclazide—type 2 diabetes mellitus	0.000202	0.00236	CcSEcCtD
Isoprenaline—Methyldopa—ADRA2A—type 2 diabetes mellitus	0.000202	0.0458	CrCbGaD
Isoprenaline—Tachycardia—Ramipril—type 2 diabetes mellitus	0.0002	0.00234	CcSEcCtD
Isoprenaline—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000198	0.00232	CcSEcCtD
Isoprenaline—Dizziness—Valsartan—type 2 diabetes mellitus	0.000196	0.00229	CcSEcCtD
Isoprenaline—Dizziness—Orlistat—type 2 diabetes mellitus	0.000193	0.00226	CcSEcCtD
Isoprenaline—Asthenia—Metformin—type 2 diabetes mellitus	0.000193	0.00226	CcSEcCtD
Isoprenaline—Hypotension—Ramipril—type 2 diabetes mellitus	0.000192	0.00224	CcSEcCtD
Isoprenaline—Nausea—Gliclazide—type 2 diabetes mellitus	0.000191	0.00224	CcSEcCtD
Isoprenaline—Insomnia—Ramipril—type 2 diabetes mellitus	0.000186	0.00217	CcSEcCtD
Isoprenaline—Headache—Valsartan—type 2 diabetes mellitus	0.000185	0.00217	CcSEcCtD
Isoprenaline—Headache—Orlistat—type 2 diabetes mellitus	0.000183	0.00214	CcSEcCtD
Isoprenaline—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000183	0.00214	CcSEcCtD
Isoprenaline—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000182	0.00214	CcSEcCtD
Isoprenaline—Levonordefrin—ADRA2A—type 2 diabetes mellitus	0.000179	0.0406	CrCbGaD
Isoprenaline—Dizziness—Metformin—type 2 diabetes mellitus	0.000178	0.00209	CcSEcCtD
Isoprenaline—Nausea—Valsartan—type 2 diabetes mellitus	0.000176	0.00206	CcSEcCtD
Isoprenaline—Nausea—Orlistat—type 2 diabetes mellitus	0.000174	0.00203	CcSEcCtD
Isoprenaline—Asthenia—Losartan—type 2 diabetes mellitus	0.000172	0.00201	CcSEcCtD
Isoprenaline—Headache—Metformin—type 2 diabetes mellitus	0.000169	0.00198	CcSEcCtD
Isoprenaline—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000168	0.00197	CcSEcCtD
Isoprenaline—Nausea—Metformin—type 2 diabetes mellitus	0.00016	0.00187	CcSEcCtD
Isoprenaline—Headache—Irbesartan—type 2 diabetes mellitus	0.000159	0.00186	CcSEcCtD
Isoprenaline—Dizziness—Losartan—type 2 diabetes mellitus	0.000158	0.00185	CcSEcCtD
Isoprenaline—Nausea—Irbesartan—type 2 diabetes mellitus	0.000151	0.00177	CcSEcCtD
Isoprenaline—Headache—Losartan—type 2 diabetes mellitus	0.00015	0.00175	CcSEcCtD
Isoprenaline—Asthenia—Ramipril—type 2 diabetes mellitus	0.000147	0.00172	CcSEcCtD
Isoprenaline—Phenylephrine—CYP1A2—type 2 diabetes mellitus	0.000144	0.0327	CrCbGaD
Isoprenaline—Nausea—Losartan—type 2 diabetes mellitus	0.000142	0.00166	CcSEcCtD
Isoprenaline—Dizziness—Ramipril—type 2 diabetes mellitus	0.000136	0.00159	CcSEcCtD
Isoprenaline—Headache—Ramipril—type 2 diabetes mellitus	0.000129	0.0015	CcSEcCtD
Isoprenaline—Droxidopa—ADRA2A—type 2 diabetes mellitus	0.000126	0.0286	CrCbGaD
Isoprenaline—Nausea—Ramipril—type 2 diabetes mellitus	0.000122	0.00143	CcSEcCtD
Isoprenaline—Norepinephrine—ADRA2A—type 2 diabetes mellitus	0.000106	0.0241	CrCbGaD
Isoprenaline—Salbutamol—CYP3A4—type 2 diabetes mellitus	9.79e-05	0.0222	CrCbGaD
Isoprenaline—Epinephrine—ADRA2A—type 2 diabetes mellitus	9.62e-05	0.0218	CrCbGaD
Isoprenaline—Epinephrine—TNF—type 2 diabetes mellitus	9.12e-05	0.0207	CrCbGaD
Isoprenaline—Norepinephrine—CYP1A2—type 2 diabetes mellitus	7.36e-05	0.0167	CrCbGaD
Isoprenaline—Dopamine—CYP1A2—type 2 diabetes mellitus	6.84e-05	0.0155	CrCbGaD
Isoprenaline—Epinephrine—CYP1A2—type 2 diabetes mellitus	6.68e-05	0.0152	CrCbGaD
Isoprenaline—Epinephrine—CYP3A4—type 2 diabetes mellitus	4.42e-05	0.01	CrCbGaD
Isoprenaline—ADRBK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.76e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	2.75e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.74e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.74e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.73e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.73e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—type 2 diabetes mellitus	2.72e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SERPINE1—type 2 diabetes mellitus	2.72e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—AKT1—type 2 diabetes mellitus	2.72e-06	1.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.72e-06	1.51e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.71e-06	1.51e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.71e-06	1.51e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—BCL2—type 2 diabetes mellitus	2.71e-06	1.51e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.69e-06	1.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.68e-06	1.5e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—EGFR—type 2 diabetes mellitus	2.68e-06	1.5e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.68e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.67e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.67e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.67e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.67e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.66e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.65e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.65e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.65e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—RELA—type 2 diabetes mellitus	2.65e-06	1.48e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.62e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.62e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.61e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.61e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.61e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.61e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.61e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—C3—type 2 diabetes mellitus	2.61e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.6e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—NOS3—type 2 diabetes mellitus	2.6e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PIK3R1—type 2 diabetes mellitus	2.6e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.59e-06	1.45e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.58e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.58e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.58e-06	1.44e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.57e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.57e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.57e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.55e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.55e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—type 2 diabetes mellitus	2.54e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.54e-06	1.42e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.53e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.53e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—type 2 diabetes mellitus	2.53e-06	1.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.52e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.52e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—AKT1—type 2 diabetes mellitus	2.51e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—type 2 diabetes mellitus	2.51e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.49e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.49e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.49e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.48e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.48e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.48e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—EGFR—type 2 diabetes mellitus	2.48e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.47e-06	1.38e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—AKT1—type 2 diabetes mellitus	2.46e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.46e-06	1.37e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	2.45e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.45e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.44e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.43e-06	1.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.43e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.43e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.42e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.41e-06	1.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—type 2 diabetes mellitus	2.41e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.4e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.4e-06	1.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.38e-06	1.33e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—type 2 diabetes mellitus	2.37e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.36e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—type 2 diabetes mellitus	2.35e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—AKT1—type 2 diabetes mellitus	2.35e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.34e-06	1.31e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.31e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—type 2 diabetes mellitus	2.31e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—AKT1—type 2 diabetes mellitus	2.31e-06	1.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.29e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.29e-06	1.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—AKT1—type 2 diabetes mellitus	2.28e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.27e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.27e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.26e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.26e-06	1.26e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.24e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—NFKB1—type 2 diabetes mellitus	2.23e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.22e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	2.22e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—AKT1—type 2 diabetes mellitus	2.22e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.22e-06	1.24e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.2e-06	1.23e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.18e-06	1.22e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	2.17e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—AKT1—type 2 diabetes mellitus	2.17e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.16e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.15e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.15e-06	1.2e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.14e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—AKT1—type 2 diabetes mellitus	2.13e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.12e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.12e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.11e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.11e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	2.11e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.11e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.11e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.1e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.09e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.08e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—SRC—type 2 diabetes mellitus	2.08e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.08e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—INS—type 2 diabetes mellitus	2.07e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.07e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.07e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	2.07e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.07e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.07e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.07e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.06e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.06e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—type 2 diabetes mellitus	2.06e-06	1.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.04e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.04e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.03e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.03e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.02e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.02e-06	1.13e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	2.01e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.99e-06	1.11e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.98e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.96e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.95e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.93e-06	1.08e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.93e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	1.92e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SRC—type 2 diabetes mellitus	1.92e-06	1.07e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.91e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.9e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.9e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—type 2 diabetes mellitus	1.9e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—type 2 diabetes mellitus	1.9e-06	1.06e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.88e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.88e-06	1.05e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	1.87e-06	1.04e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.84e-06	1.03e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	1.82e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EGFR—type 2 diabetes mellitus	1.82e-06	1.02e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.82e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.82e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—type 2 diabetes mellitus	1.81e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.8e-06	1.01e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.8e-06	1e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.77e-06	9.86e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	1.77e-06	9.85e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—type 2 diabetes mellitus	1.76e-06	9.79e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.74e-06	9.69e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.73e-06	9.67e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.73e-06	9.64e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	1.73e-06	9.63e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.73e-06	9.62e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—type 2 diabetes mellitus	1.72e-06	9.57e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.71e-06	9.54e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.71e-06	9.53e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.71e-06	9.52e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.7e-06	9.48e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.7e-06	9.48e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.7e-06	9.46e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.69e-06	9.43e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EGFR—type 2 diabetes mellitus	1.68e-06	9.38e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.67e-06	9.32e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.67e-06	9.31e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.66e-06	9.27e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.64e-06	9.17e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.64e-06	9.16e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.62e-06	9.05e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.62e-06	9.03e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.62e-06	9.01e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.61e-06	8.97e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.59e-06	8.87e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.59e-06	8.85e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.55e-06	8.64e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.55e-06	8.64e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.54e-06	8.6e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.53e-06	8.55e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.52e-06	8.46e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.52e-06	8.45e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.52e-06	8.45e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.49e-06	8.33e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—type 2 diabetes mellitus	1.47e-06	8.2e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.46e-06	8.13e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.46e-06	8.13e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.44e-06	8.04e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.43e-06	7.95e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.41e-06	7.89e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-06	7.82e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—type 2 diabetes mellitus	1.4e-06	7.81e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.38e-06	7.67e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.34e-06	7.5e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.33e-06	7.43e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.33e-06	7.4e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.32e-06	7.33e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.31e-06	7.3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.31e-06	7.29e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.3e-06	7.25e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-06	7.24e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—type 2 diabetes mellitus	1.29e-06	7.21e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—type 2 diabetes mellitus	1.29e-06	7.21e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.29e-06	7.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.28e-06	7.13e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.26e-06	7.03e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	6.93e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	6.86e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.23e-06	6.85e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.22e-06	6.78e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.21e-06	6.72e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.21e-06	6.72e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.21e-06	6.72e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	6.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.2e-06	6.7e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.2e-06	6.69e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—type 2 diabetes mellitus	1.19e-06	6.65e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-06	6.57e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-06	6.57e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.15e-06	6.39e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	6.25e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.12e-06	6.22e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	6.15e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	6.09e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	5.71e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1e-06	5.6e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-06	5.59e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.82e-07	5.48e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—type 2 diabetes mellitus	9.06e-07	5.05e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.36e-07	4.66e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.72e-07	4.3e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.55e-07	4.21e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.12e-07	3.97e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.97e-07	3.88e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	5.54e-07	3.09e-06	CbGpPWpGaD
